Skip to content
GLP-1 Decoder

GLP-1 and DPP-4 Inhibitors Together: Is It Safe? Label

Usually not combined: a DPP-4 pill like Januvia adds no extra sugar lowering on a GLP-1.

Verdict
Avoid together
Label names it
0 of 10
General caution
Pills absorbed more slowly

Check a GLP-1 interaction

Weight loss and half-life summary

How long each medicine remains in your body
Wegovy7 dOzempic7 dRybelsus7 dZepbound5.5 dMounjaro5 dTrulicity5 dFoundayo1.6 dSaxenda0.5 dVictoza0.5 dByetta0.1 d

Half-life in days means how long your body takes to remove half a dose. This comes from section 12.3 in each FDA label.

Each medicine’s main weight trial and the weight lost
Zepbound20.9%Wegovy14.9%Foundayo11.1%Saxenda7.4%

Percentage of body weight. Each trial uses different doses and lengths, so compare its results with the placebo listed on that same page.

Sources (10)

From the FDA label (DailyMed): 1 2 3 4 5 6 7 8 9 10.

The verdict on DPP-4 inhibitors and GLP-1

Avoid together

The Ozempic label’s drug interactions section says the following, word for word:

“OZEMPIC causes a delay of gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications. In clinical pharmacology trials,”

Source: FDA label (DailyMed).

What the GLP-1 label says

The Ozempic label does not name DPP-4 inhibitors, such as Januvia. It still falls under those same lines.

Drug interactions in the Ozempic label
Named in the labelThe riskWhat the label tells doctors
Insulin or sulfonylureasLow blood sugarLow blood sugar is more likely if you combine this medicine with insulin or a sulfonylurea, including glipizide or glimepiride. Your doctor may reduce those doses.
Oral medicinesPills absorbed differentlyThe medicine slows stomach emptying, which can change how other pills are absorbed.

Source: Ozempic label (DailyMed).

What the studies show

Sources: diabetesjournals.org, FDA label (DailyMed).

The practical rule

  1. If both are on your list, ask your prescriber if you still need the Januvia.
  2. Tell whoever prescribes your GLP-1 about every pill you take, including this one.
  3. Ask your pharmacist if any of your pills needs a steady blood level. After you start treatment or increase the dose, those might need a check.
  4. During the first weeks, test your blood sugar more often. Do the same after every dose increase.

Source: FDA label (DailyMed).

DPP-4 inhibitors with other GLP-1s

None of the 10 GLP-1 labels names DPP-4 inhibitors such as Januvia in the drug interaction section. Every drug in this class gives the same general warning about pills you swallow, so the answer does not change across the class.

Source: FDA label (DailyMed).